Novartis switches gears in Shanghai from research to drug development
ZURICH (Reuters) – Novartis is exiting drug discovery at its Shanghai site and shifting its...
Read MoreNov 18, 2019
ZURICH (Reuters) – Novartis is exiting drug discovery at its Shanghai site and shifting its...
Read MoreNov 18, 2019
BEIJING (Reuters) – Some people who had been in close contact with pneumonic plague patients from Inner Mongolia have been released from medical observation, China’s health authority said on Monday. Out of 46 close...
Read MoreNov 18, 2019
(Reuters) – Merck & Co Inc <MRK.N said on Monday an experimental treatment being...
Read MoreNov 18, 2019
By Aditya Kalra NEW DELHI (Reuters) – The Indian government has told a court that its...
Read MoreNov 18, 2019
BEIJING (Reuters) – China’s Inner Mongolia reported a fresh, confirmed case of bubonic plague on Sunday, despite an earlier declaration by the country’s health officials that the risk of an outbreak was...
Read MoreNov 18, 2019
SHANGHAI (Reuters) – China reported a third case of bubonic plague on Sunday after two other plague cases were revealed last week, but the disease remains rare despite its fearsome reputation and authorities say the cases...
Read MoreNov 18, 2019
BEIJING (Reuters) – China’s agriculture ministry said on Monday it will launch an investigation into the illegal production, sale and use of African swine fever vaccines in the country, citing online reports of their...
Read MoreNov 16, 2019
By Lidia Kelly MELBOURNE (Reuters) – Samoa declared a state of emergency this weekend, closing all schools and cracking down on public gatherings, after several deaths linked to a measles outbreak that has spread across...
Read MoreNov 16, 2019
By Julie Steenhuysen CHICAGO (Reuters) – Many patients with severe but stable heart disease...
Read MoreNov 16, 2019
(The Nov 16 story corrects to clarify in second graph that patients will be infused by a...
Read MoreNov 15, 2019
By Nate Raymond and Jonathan Stempel (Reuters) – An Oklahoma judge on Friday said Johnson...
Read MoreNov 15, 2019
(Reuters) – China-based drugmaker BeiGene Ltd on Friday priced its drug, Brukinsa, to treat a rare form of lymphoma at $12,935 for a 30-day supply. The U.S. Food and Drug Administration on Thursday approved the drug,...
Read MoreNov 15, 2019
By Lisa Rapaport (Reuters Health) – Many children are injured by lawnmowers despite safety guidelines in place to prevent these accidents, and kids in rural communities are most at risk, a U.S. study suggests. Researchers...
Read MoreNov 15, 2019
By Linda Carroll (Reuters Health) – When insurance covers in vitro fertilization, more women struggling with infertility, especially those with limited financial resources, will use the method to improve their chances of...
Read MoreNov 15, 2019
WASHINGTON (Reuters) – President Donald Trump said on Friday he would be giving U.S. states...
Read MoreNov 15, 2019
(Reuters) – The U.S. Food and Drug Administration said on Friday it had cleared medical equipment maker Pentax of America’s duodenoscope, which is designed to be easier to disinfect and clean than traditional...
Read MoreNov 15, 2019
By Vishwadha Chander (Reuters Health) – There’s demand among U.S. women for an online service offering abortion medication, and it’s driven mainly by restrictive abortion policies, but also by high costs,...
Read MoreNov 15, 2019
By Kate Kelland LONDON (Reuters) – Chronic smokers who switched from tobacco cigarettes to...
Read MoreNov 15, 2019
ZURICH (Reuters) – Swiss drugmaker Roche is paying up to $1.4 billion to buy U.S. biotech...
Read MoreNov 15, 2019
By Carolyn Crist (Reuters Health) – Across the world, imprisoned women have higher rates of cervical cancer and the human papillomavirus (HPV) infection that can lead to cancer, according to a research review. Screening...
Read More